Ikarian Capital »

Roivant Sciences Ltd Shs Isin #bmg762791017 shares owned by Ikarian Capital

Quarter-by-quarter ownership of Roivant Sciences Ltd Shs Isin #bmg762791017 (ROIV) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Roivant Sciences Ltd Shs Isin #bmg762791017

Tip: Access up to 7 years of quarterly data

All positions including Roivant Sciences Ltd Shs Isin #bmg762791017 held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Roivant Sciences Ltd Shs Isin #bmg762791017 by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.7M 152k 11.23
2023-09-30 $21k 1.8k 11.68
2023-06-30 $2.3M 225k 10.08
2023-03-31 $4.2M 575k 7.38

More positions owned by Ikarian Capital

Argenx Se Sponsored Adr (ARGX)
Krystal Biotech Call Option (KRYS)
Cytokinetics Com New (CYTK)
Alnylam Pharmaceuticals Call Option (ALNY)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Crispr Therapeutics Namen Akt (CRSP)
Eli Lilly & Co. Put Option (LLY)
Sarepta Therapeutics (SRPT)
Prothena Corp SHS Call Option (PRTA)
Amylyx Pharmaceuticals (AMLX)
Nuvalent Inc-a (NUVL)
Immunovant (IMVT)
Crinetics Pharmaceuticals In (CRNX)
Soleno Therapeutics (SLNO)
Eyepoint Pharmaceuticals Com New (EYPT)

View all positions for Ikarian Capital

Top funds holding Roivant Sciences Ltd Shs Isin #bmg762791017

QVT Financial
Viking Global Investors
Wellington Management Company
Baker Bros. Advisors
Vanguard Group
Anchorage Capital Group
venBio Select Advisor
T. Rowe Price Associates
Citadel Advisors
Norges Bank Investment Management
BVF
Bank of New York Mellon
Octagon Capital Advisors
Tejara Capital
Charles Schwab Investment Management

View all funds holding Roivant Sciences Ltd Shs Isin #bmg762791017